🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
JNJ
NYSE
🇺🇸 US
Johnson & Johnson
Healthcare
22Score
DipBuster Score™
$228.39
$5.81 (0%)
Live price · Source: FMP-live
52-Week Position
$149.04
77% of range
$251.71
Beta
0.256
Low vol
Dividend
—
no income
Mkt Cap
$549.78B
total value
Mkt Cap$549.78B
P/EN/A
DividendNone
Beta0.256
52W High$251.71
52W Low$149.04
🤖
Not a Dip — Score 22/100
Zone: Consider Trimming
🔒 Unlock Pro
Valuation
P/E Ratio—
Mkt Cap$549.78B
52W Position77% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.256
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️
Insider Buys
Track director & CEO open-market purchases
📊
Valuation Analysis
P/E, EV/EBITDA, DCF & NCAV metrics
📈
Financial Charts
Revenue, EBITDA, FCF & balance sheet trends
🤖
AI Analysis
Plain-English explanation of every key metric
Sign up free — charts & fundamentals included
Get financial charts, valuation data, dividends & news for Johnson & Johnson free. Upgrade to Pro for insider signals & AI analysis.
Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
9/25
Momentum & Volume
8/25
Quality & Size
5/10
Insider Activity
0/10
Quick Take
⚪
Not a Dip
DipBuster Score: 22/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Johnson & Johnson (JNJ) operates globally, engaging in the research, development, production, and distribution of a diverse range of healthcare products. In a pivotal strategic move in 2023, the company divested its Cons…
Sector
Healthcare
Market
🇺🇸 US
CEO
Joaquin Duato
Staff
138,100 employees
Website